These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3370812)

  • 1. Is the TDx digoxin assay really overestimating?
    Grazioli V; Banfi G; Murone M; Bonini PA
    Clin Chem; 1988 May; 34(5):994-5. PubMed ID: 3370812
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of digoxin-like immunoreactive substances on the "Dac-Cel" digoxin assay.
    Smith RL
    Clin Chem; 1987 Sep; 33(9):1697. PubMed ID: 3621591
    [No Abstract]   [Full Text] [Related]  

  • 3. Digoxin-like immunoreactive substance in renal failure: a reappraisal.
    Greenway DC; Nanji AA
    Nephron; 1986; 44(2):108-10. PubMed ID: 3774074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interference of digoxin-like immunoreactive substances with TDx digoxin II assay in different patients.
    Avendaño C; Alvarez JS; Sacristan JA; Adin J; Alsar MJ
    Ther Drug Monit; 1991 Nov; 13(6):523-7. PubMed ID: 1771650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interference from digoxin-like immunoreactive substance(s) in commercial digoxin kit assay methods.
    Morris RG; Frewin DB; Saccoia NC; Goldsworthy WL; Jeffries WS; McPhee AJ
    Eur J Clin Pharmacol; 1990; 39(4):359-63. PubMed ID: 2076718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disposable-column radioimmunoassay for serum digoxin with less interference from metabolites and endogenous digitalis-like factors.
    Longerich L; Vasdev S; Johnson E; Gault MH
    Clin Chem; 1988 Nov; 34(11):2211-6. PubMed ID: 2846204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assay for digoxin-like immunoreactive substance--loss of sensitivity.
    Ho CS; Swaminathan R
    Clin Chem; 1988 Dec; 34(12):2604. PubMed ID: 3197324
    [No Abstract]   [Full Text] [Related]  

  • 8. Digoxin-like substance(s) interfere(s) with serum estimations of the drug in cirrhotic patients.
    Nikou GC; Vyssoulis GP; Venetikou MS; Karga HI; Karoutsos KA; Toutouzas PK
    J Clin Gastroenterol; 1989 Aug; 11(4):430-3. PubMed ID: 2547866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific interaction between antidigoxin antibodies and digoxin-like immunoreactive substances in cord serum.
    Scherrmann JM; Sandouk P; Guedeney X
    Clin Chem; 1986 Jan; 32(1 Pt 1):97-100. PubMed ID: 3753588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous digoxin-immunoactive factor in human subjects.
    Valdes R
    Fed Proc; 1985 Sep; 44(12):2800-5. PubMed ID: 3839758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of antibody specificity on results of selected digoxin immunoassays among various clinical groups.
    Datta P; Xu L; Malik S; Landicho D; Ferreri L; Halverson K; Roby PV; Zebelman AM; Kenny MA
    Clin Chem; 1996 Mar; 42(3):373-9. PubMed ID: 8598098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Higher values for digitalis-like factors with TDx Digoxin II.
    Gault MH; Vasdev S; Longerich L
    Clin Chem; 1986 Oct; 32(10):2000-1. PubMed ID: 3757253
    [No Abstract]   [Full Text] [Related]  

  • 13. [Determination of blood digoxin].
    Janssen K
    Dtsch Med Wochenschr; 1990 Aug; 115(33):1254. PubMed ID: 2201511
    [No Abstract]   [Full Text] [Related]  

  • 14. Positive interference of merthiolate in the TDx digoxin assay in control samples used in the Belgian External Quality Assessment (EQA) Scheme.
    Devleeschouwer N; Libeer JC; Schiettecatte J; Maes V; Demolder J; Debusschere PM; Gorus F
    Eur J Clin Chem Clin Biochem; 1994 Dec; 32(12):935-7. PubMed ID: 7696443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Digoxin radioimmunoassay that does not detect digoxin-like substance in serum of newborns, infants, or patients with renal failure.
    Witherspoon L; Shuler S; Neely H; Sonnemaker R; Alyea K; Gilbert S
    Clin Chem; 1987 Mar; 33(3):420. PubMed ID: 3815819
    [No Abstract]   [Full Text] [Related]  

  • 16. Inaccuracies in digoxin measurement.
    Cook JD; Koch TR; Cook MS; Knoblock EC
    Clin Biochem; 1988 Dec; 21(6):353-7. PubMed ID: 3233747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of renal impairment on a new time-resolved fluoroimmunoassay for serum digoxin.
    Paterson NC; Stewart MJ
    Ann Clin Biochem; 1987 Mar; 24 ( Pt 2)():205-6. PubMed ID: 3592569
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of assay methodologies and interferences on the interpretation of digoxin concentrations.
    Fitzsimmons WE
    Drug Intell Clin Pharm; 1986; 20(7-8):538-42. PubMed ID: 3755675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A physician's office-based digoxin assay (Seralyzer) evaluated for interference by endogenous digoxin-like immunoreactive factors.
    Matheke ML; Valdes R
    Ann Clin Lab Sci; 1989; 19(3):168-74. PubMed ID: 2658726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Digoxin-like immunoreactive substance in the elderly patient and its impact on the TDx digoxin assay.
    Yamamoto T; Takano K; Sanaka M; Nomura Y; Koike Y; Mineshita S
    Ther Drug Monit; 1998 Aug; 20(4):417-21. PubMed ID: 9712467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.